Cervical cancer, Prostate cancer, Womb (uterine or endometrial) cancer
Results
Phase 2/3
This trial was looking at whether a carbohydrate called fructo-oligosaccharide (FOS) could help reduce bowel problems after radiotherapy for prostate cancer or gynaecological cancer.
Unfortunately, if part of the bowel is in the area treated with radiotherapy, it can become inflamed causing diarrhoea, bleeding and discomfort or pain. For most people these symptoms go away within a few weeks of finishing radiotherapy. But for some people they can be more long term. Doctors call this chronic radiation enteritis.
Sometimes, chronic radiation enteritis can get worse over time. Researchers thought that encouraging healthy bacteria to grow in the bowel may help to control chronic radiation enteritis.
FOS is a natural carbohydrate found in many foods. It stimulates the growth of healthy bacteria in the bowel and is called a prebiotic. In a small trial, FOS had changed the number of healthy bacteria in people with inflammation of the bowel. And this had improved their symptoms.
The aim of this trial was to find out if FOS could reduce bowel problems after radiotherapy for prostate cancer or gynaecological cancer.
Recruitment start: 1 January 2010
Recruitment end: 28 February 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Alastair Forbes
Beneo Orafti
University College London (UCL)
Last reviewed: 12 November 2013
CRUK internal database number: 9319